非肌层浸润性膀胱癌主动监测失败的长期随访及相关因素:BIAS研究经验
该研究基于意大利主动监测膀胱癌(BIAS)项目,纳入低级别pTa/pT1a非肌层浸润性膀胱癌复发后接受主动监测(AS)的患者,分析长期结局及AS失败相关因素。共251次AS事件中130次失败(51.8%),最终病理显示25例良性病变(19.2%)、92例低级别Ta(70.7%)、12例高级别Ta/T1(9.2%)、1例T2(0.7%)。多因素Cox回归证实多次经尿道电切(TUR)史(HR 1.59,95%CI 1.01-2.51)和AS入组时病灶数>1(HR 1.63,95%CI 1.05-2.54)与AS失败风险显著相关。
要点
- 低级别pTa/pT1a复发NMIBC患者经严格筛选可安全长期接受主动监测。
- 多次TUR史(HR 1.59)和AS入组时多发病灶(HR 1.63)增加AS失败风险。
- AS失败者最终病理多为低级别Ta(70.7%),少数为高级别或T2(9.2%和0.7%)。
核心结论
- 严格选择的复发性低级别NMIBC患者可安全长期接受主动监测,多次TUR史和多发病灶与AS失败风险升高相关。
研究设计与样本
- 基于BIAS项目,纳入低级别pTa/pT1a NMIBC复发后接受AS的患者,共分析251次AS事件。
主要发现
- 251次AS事件中130次失败(51.8%),失败者最终病理为良性病变25例(19.2%)、低级别Ta 92例(70.7%)、高级别Ta/T1 12例(9.2%)、T2 1例(0.7%)。
- 12、18、24、36个月无治疗概率分别为59.7%、54.5%、46.3%、40.4%。
- 95例患者(37.8%)维持AS超过18个月。
- 多因素Cox回归显示多次TUR史(HR 1.59,95%CI 1.01-2.51)和AS入组时病灶数>1(HR 1.63,95%CI 1.05-2.54)与AS失败风险显著相关。
临床怎么用
- 对低级别pTa/pT1a复发NMIBC患者,在严格筛选后可考虑主动监测以推迟或避免手术。
- 评估AS候选者时需关注既往TUR次数和AS入组时病灶数目,以识别高失败风险患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Active surveillance (AS) has been proposed as an alternative to transurethral resection (TUR) in selected patients with recurrent low-risk non-muscle-invasive bladder cancer (NMIBC). Here we report long-term results for patients on AS and investigate features associated with AS failure. Cases with recurrence after diagnosis of low-grade (LG) pTa/pT1a NMIBC were enrolled in the Bladder Italian Active Surveillance (BIAS) project. Over 251 AS events, we observed 130 failures (51.8%). In these patients, final pathology showed 25 benign lesions (19.2%) and 92 LG Ta (70.7%), 12 high-grade Ta/T1 (9.2%), and one T2 (0.7%) tumor. The treatment-free probability at 12, 18, 24, and 36 mo was 59.7%, 54.5%, 46.3%, and 40.4%, respectively. We identified 95 patients (37.8%) who remained on AS for >18 mo. A multivariable Cox regression model confirmed that patients with a history of multiple TURs (hazard ratio [HR] 1.59, 95% confidence interval [CI] 1.01-2.51) and those with more than one lesion at AS entry (HR 1.63, 95% CI 1.05-2.54) were significantly more likely to experience AS failure. Our results confirm that well-selected patients with NMIBC can safely remain on AS for a long period of time. Multiple TURs and multiple lesions at AS enrollment are associated with a higher risk of AS failure. PATIENT SUMMARY: Active surveillance has been proposed as an alternative to surgery for patients with recurrent low-risk superficial bladder cancer. Our report confirms that well-selected patients can safely avoid or postpone surgery.
引用
- Contieri R, Paciotti M, Lughezzani G, et al. Long-term Follow-up and Factors Associated with Active Surveillance Failure for Patients with Non-muscle-invasive Bladder Cancer: The Bladder Cancer Italian Active Surveillance (BIAS) Experience. Eur Urol Oncol. 2021. PMID: 34059485. doi:10.1016/j.euo.2021.05.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。